ARTICLE
2 October 2017

MACRA Deadline: It's Not Too Late To Avoid A Negative Payment Adjustment

HL
Horne LLP
Contributor
Horne LLP
In earlier blogs on MACRA, we've discussed a series of topics, including the flexibility in the first reporting year 2017 and the "Pick Your Pace" option in MIPS.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

In earlier blogs on MACRA, we've discussed a series of topics, including the flexibility in the first reporting year 2017 and the "Pick Your Pace" option in MIPS.

CMS recognized that practices will not approach the QPP in the same way and is treating 2017 as a transition year in an effort to make it easier for clinicians to receive a neutral or positive payment adjustment in MIPS. It is also allowing time for clinicians and CMS to build their capabilities and gain valuable experience.

One of the options in the "Pick Your Pace" transition year is for eligible clinicians to report for a minimum of 90 consecutive days of data to increase their chances to qualify for a positive MIPS payment adjustment and avoid the 4% reduction. In order to meet the 90 consecutive days of data submitted, practices need to start accurately recording relevant data no later than October 2, 2017.

To avoid a negative payment adjustment, submit a minimum amount of 2017 data to Medicare; for example, one quality measure or one improvement activity for any time in 2017.

Resources are available for download from our toolkit that provides data and checklists to help you succeed in new payment models.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

ARTICLE
2 October 2017

MACRA Deadline: It's Not Too Late To Avoid A Negative Payment Adjustment

United States Food, Drugs, Healthcare, Life Sciences
Contributor
Horne LLP
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More